Blog

Feb 7, 2025, 13:15

Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma

Roni Shouval, Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on X:

“New study out! Early (2nd-line) vs late (≥3rd-line) CAR-T in LBCL. While early CAR-T trended toward better OS (82% vs. 71%, p<.048), relapse remained high in both (37% vs. 43%, p=.2), challenging the idea that earlier use overcomes resistance. ”

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma | Bone Marrow Transplantation

Authors: Magdalena Corona, Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Jessica R. Flynn, Sean M. Devlin, Ivan Landego, Giulio Cassanello, Kai Rejeski, Tsila Zuckerman, Parastoo B. Dahi, Michael Scordo, Richard J. Lin, Maciej Kabat, Efrat Luttwak, Emma Pavkovic, M. Lia Palomba, Jae Park, Gilles Salles, Heiko Schoder, Doris Leithner, Lori A. Leslie, Miguel-Angel Perales, Ofrat Beyar-Katz, Gunjan L. Shah and Roni Shouval

Alejandro Luna Andrew Ip cancer Doris Leithner Efrat Luttwak Emma Pavkovic Gilles Salles Giulio Cassanello Gunjan L. Shah Hazim Khatib Heiko Schoder Ivan Landego Jae Park Jessica R. Flynn Kai Rejeski Lori A. Leslie M Lia Palomba Maciej Kabat Magdalena Corona Michael Scordo Miguel-Angel Perales Ofrat Beyar-Katz OncoDaily Oncology Parastoo B Dahi Richard J Lin Roni Shouval Samantha Brown Sean M. Devlin Tsila Zuckerman

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers